1. Home
  2. GPCR vs FOXF Comparison

GPCR vs FOXF Comparison

Compare GPCR & FOXF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • FOXF
  • Stock Information
  • Founded
  • GPCR 2016
  • FOXF 2007
  • Country
  • GPCR United States
  • FOXF United States
  • Employees
  • GPCR N/A
  • FOXF N/A
  • Industry
  • GPCR
  • FOXF Motor Vehicles
  • Sector
  • GPCR
  • FOXF Consumer Discretionary
  • Exchange
  • GPCR Nasdaq
  • FOXF Nasdaq
  • Market Cap
  • GPCR 1.8B
  • FOXF 1.5B
  • IPO Year
  • GPCR 2023
  • FOXF N/A
  • Fundamental
  • Price
  • GPCR $40.36
  • FOXF $39.51
  • Analyst Decision
  • GPCR Buy
  • FOXF Hold
  • Analyst Count
  • GPCR 6
  • FOXF 6
  • Target Price
  • GPCR $81.33
  • FOXF $46.17
  • AVG Volume (30 Days)
  • GPCR 593.8K
  • FOXF 449.7K
  • Earning Date
  • GPCR 08-08-2024
  • FOXF 10-31-2024
  • Dividend Yield
  • GPCR N/A
  • FOXF N/A
  • EPS Growth
  • GPCR N/A
  • FOXF N/A
  • EPS
  • GPCR N/A
  • FOXF 0.98
  • Revenue
  • GPCR N/A
  • FOXF $1,345,575,000.00
  • Revenue This Year
  • GPCR N/A
  • FOXF N/A
  • Revenue Next Year
  • GPCR N/A
  • FOXF $10.38
  • P/E Ratio
  • GPCR N/A
  • FOXF $40.07
  • Revenue Growth
  • GPCR N/A
  • FOXF N/A
  • 52 Week Low
  • GPCR $26.61
  • FOXF $34.56
  • 52 Week High
  • GPCR $75.02
  • FOXF $105.38
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 57.92
  • FOXF 49.18
  • Support Level
  • GPCR $38.27
  • FOXF $34.56
  • Resistance Level
  • GPCR $42.67
  • FOXF $40.66
  • Average True Range (ATR)
  • GPCR 2.29
  • FOXF 1.46
  • MACD
  • GPCR 0.31
  • FOXF 0.23
  • Stochastic Oscillator
  • GPCR 76.72
  • FOXF 82.08

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About FOXF Fox Factory Holding Corp.

Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World.

Share on Social Networks: